IN FOCUS: Solvias
Pharmaceutical Technology
DECEMBER 9, 2022
Beyond our expertise in small molecules, we have built a solid reputation with biopharmaceutical companies for the characterisation and analysis of monoclonal antibodies, therapeutic proteins and biosimilars. Assays to support mRNA-based Covid-19 vaccines. Biopharmaceutical analytical services. HQ ADDRESS: Römerpark 2. Switzerland.
Let's personalize your content